Weber Barbara
SEC CIK 1800670 · EDGAR
BoughtSold
Most active insiders at TNGX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRV GP IV, LLC | 10% | — | $8.86M |
| 2 | Crystal Adam | Pres, R, D | — | $6.33M |
| 3 | Weber Barbara | Dir, Executive COB | — | $374.4K |
| 4 | Newcomb Jessica | Principal Accounting Off | — | $198.6K |
| 5 | Beckman Daniella | CFO | — | $126.6K |
| 6 | Ketchum John B | Dir | — | — |
| 7 | Peters Malte | Pres, CEO, Dir | — | — |
| 8 | Rothenberg Mace | Dir | — | — |
| 9 | Gall Matthew | CFO | — | — |
| 10 | Lee Sung | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-04 | 2026-02-03 | TNGX | Tango Therapeutics, Inc. | Weber Barbara | Dir, Executive COB | S - Sale | $12.27 | -30.5K | 1.63M | -2% | -$374.4K |
| D | 2026-02-04 | 2026-02-02 | TNGX | Tango Therapeutics, Inc. | Weber Barbara | Dir, Executive COB | A - Grant | $0.00 | +37.5K | 1.66M | +2% | $0 |
| M | 2025-02-06 | 2025-02-04+ | TNGX | Tango Therapeutics, Inc. | Weber Barbara | CEO, Dir | S - Sale | $3.07 | -18.8K | 1.62M | -1% | -$57.7K |
| D | 2025-02-05 | 2025-02-03 | TNGX | Tango Therapeutics, Inc. | Weber Barbara | CEO, Dir | A - Grant | $0.00 | +105.9K | 1.64M | +7% | $0 |
| T | 2024-10-10 | 2024-10-08 | RVMD | Revolution Medicines, Inc. | Weber Barbara | Dir | S - Sale | $48.02 | -5,200 | 13.1K | -28% | -$249.7K |
| 2024-08-23 | 2024-08-21 | RVMD | Revolution Medicines, Inc. | Weber Barbara | Dir | D - Sale to Iss | $44.83 | -1,808 | 18.3K | -9% | -$81.1K | |
| DA | 2024-06-28 | 2024-06-20 | RVMD | Revolution Medicines, Inc. | Weber Barbara | Dir | A - Grant | $0.00 | +4,248 | 20.1K | +27% | $0 |
| D | 2024-06-24 | 2024-06-20 | RVMD | Revolution Medicines, Inc. | Weber Barbara | Dir | A - Grant | $0.00 | +4,800 | 20.6K | +30% | $0 |
| M | 2024-02-08 | 2024-02-06+ | TNGX | Tango Therapeutics, Inc. | Weber Barbara | CEO, Dir | S - Sale | $12.59 | -9,138 | 1.54M | -0.6% | -$115.0K |
| D | 2024-02-05 | 2024-02-01 | TNGX | Tango Therapeutics, Inc. | Weber Barbara | CEO, Dir | A - Grant | $0.00 | +87.2K | 87.2K | New | $0 |
| D | 2023-09-06 | 2023-09-01 | RVMD | Revolution Medicines, Inc. | Weber Barbara | Dir | S - Sale+OE | $35.07 | -15.0K | 15.8K | -49% | -$526.0K |
| DM | 2023-09-06 | 2023-09-01 | RVMD | Revolution Medicines, Inc. | Weber Barbara | Dir | M - OptEx | $3.80 | +15.0K | 30.8K | +95% | +$57.0K |
| D | 2023-06-12 | 2023-06-08 | RVMD | Revolution Medicines, Inc. | Weber Barbara | Dir | A - Grant | $0.00 | +5,200 | 15.8K | +49% | $0 |
| D | 2023-03-02 | 2023-03-01 | TNGX | Tango Therapeutics, Inc. | Weber Barbara | CEO, Dir | A - Grant | $0.00 | +89.5K | 1.46M | +7% | $0 |
| D | 2022-06-17 | 2022-06-16 | RVMD | Revolution Medicines, Inc. | Weber Barbara | Dir | A - Grant | $0.00 | +5,200 | 10.6K | +96% | $0 |
Purchase Sale Sale after option exercise All abbreviations